Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from BioSpace

11:12 EDT 17th October 2017 | BioPortfolio

Here are the most relevant search results for "BioSpace" found in our extensive news archives from over 250 global news sources.

More Information about BioSpace on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioSpace for you to read. Along with our medical data and news we also list BioSpace Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioSpace Companies for you to search.

Showing News Articles 1–25 of 21,000+ from BioSpace

Thursday 12th October 2017

Tauriga Fully Retires Original $96,000 USD 12.00% Convertible Debenture Issued To On July 14, 2015

NEW YORK, NY--(Marketwired - October 13, 2017) - Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), a company engaged in building businesses in the life sciences space, today announced that it has fully retired the original face value of $96,000 USD 12.00% convertible debenture (the "Note...

W. R. Grace & Company Acquires Exclusive License Of Ordered Mesoporous Silica Patents For Drug Delivery From

COLUMBIA, MD. Oct. 9, 2017 W. R. Grace & Co. announces that it has acquired from Formac Pharmaceuticals NV exclusive licensing rights on multiple patents and know-how for ordered mesoporous silica-based technology to enhance the oral bioavailability of active pharmaceutical ingredients (APIs).Grace and Formac formed a strategic partnership in 2011 to jointly de...

Otoharmonics Corporation Appoints Senior Vice President of Sales

PORTLAND, Ore., Oct. 13, 2017 /PRNewswire/ --Otoharmonics continues to expand its sales leadership team with the hire of Joel Ellis, Senior Vice President of Sales. Fulfilling the latest step in Otoharmonics' growth strategy, Joel joins the team with over 20 years of experience...

Medibio Completes Heavily Oversubscribed Institutional Placement For $13.9 Million To Accelerate Commercialisation

Highlights: Placement completed, with oversubscriptions accepted up to $13.9 MillionFidelity Investments follows on to maintain 10.6% ownership of the CompanyIFM Investors and Regal FM to become substantial shareholders post-transactionMedibio now fully funded to...

EPGL Contact Lens Technology Chosen For Development By First Major Public Company

IRVINE, CA--(Marketwired - October 12, 2017) - Highlighted Links InWith Corporation EP Global Communications, Inc. EP Global Communications, Inc.

InspireMD Announces Distribution Agreement For MGuard Prime In Chile

TEL AVIV, ISRAEL--(Marketwired - October 12, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with CorpMedical...

AroCell AB: Announces That A Distribution Agreement Has Been Signed With Pathway Diagnostics, For Distribution Of The Arocell TK 210 ELISA Test In United Kingdom And Ireland

"We very much look forward to this new collaboration with the England based Pathway Diagnostics for the distribution of our TK 210 ELISA test", states Jan Stlemark, AroCell CEO. "Pathway Diagnostics Ltd is a leading supplier of specialist clinical and research diagnostics in the UK and was established in 1998 to provide high quality in-vitro diagnostic produc...

AACC Elects New Leaders To Serve In 2018

WASHINGTON, Oct. 13, 2017 /PRNewswire-USNewswire/ -- AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Carmen L. Wiley, PhD, DABCC, FACB, has been elected to serve on the AACC Board...

Swift Biosciences Launches Accel-Amplicon Custom NGS Panels, Accelerating Variant Discovery In Challenging Biological Samples

ANN ARBOR, Mich., Oct. 13, 2017 /PRNewswire/ -- 

NEMUS Bioscience Provides Further Update On Previously Announced $20 Million Schneider Financing

COSTA MESA, CA--(Marketwired - October 13, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) (the "Company") today announced a further update to its news releases dated May 4, 2017 and July 11, 2017 with respect to the signing of a private placement with Schneider Finance LLC, an affiliate of Schneider Brothers...

Angle Announces Proposed Further Subscription For ?? 2.8 Million

GUILDFORD, SURREY--(Marketwired - October 12, 2017) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY)AIM:AGL OTCQX:ANPCYFor immediate release 12 October 2017ANGLE plc ("the Company")PROPOSED FURTHER SUBSCRIPTION FOR £ 2.8 MILLION...

Elsalys Biotech Acquires From Jazz Pharma The Worldwide Rights Of Leukoteac

ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC, an immunotherapy antibody with clinical benefits in steroid-resistant acute Graft-versus-Host Disease ...

Prime Therapeutics Study Finds A Diabetes Drugs Value Based Insurance Design Improves Adherence, Doesn't Lower Total Cost Of Care

ST. PAUL, Minn., Oct. 13, 2017 /PRNewswire/ --Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 20 million members nationally, found that implementing value based insurance designs (VBID) does not lead...

Shire Release: New Formulation Of ONCASPAR (Pegaspargase) Receives Positive Opinion In Europe For Patients With Acute Lymphoblastic Leukemia (ALL)

New Formulation of ONCASPAR (pegaspargase) Receives Positive CHMP Opinion in Europe for Patients with Acute Lymphoblastic Leukemia (ALL) If approved, lyophilized formulation would offer three times longer shelf life vs. liquid ONCASPAR, enabling better supply management and...

ASIT Biotech Announces The Publication Of Its First Clinical Data With gp-ASIT+ In /i>

BRUSSELS--(BUSINESS WIRE)--Regulatory News: ...

Merit Medical To Announce Third Quarter Results On October 25, 2017

SOUTH JORDAN, Utah, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the quarter ended September...

ConforMIS To Host Third Quarter 2017 Financial Results Conference Call And Webcast On November 1, 2017

BILLERICA, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, November 1, 2017, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter 2017. To participate in the conference call, please call 877-8...

Olympus Medical Systems Corp. Announces Continued Expansion Of Its GI Endoscopic Device Line With ESD Innovations

CENTER VALLEY, Pa., Oct. 13, 2017 /PRNewswire/ --Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the expansion of its EndoTherapy product line, building on the company's commitment to innovation...

Royal Philips Electronics N.V. Receives U.S. FDA 510(K) Clearance to Market its Solution For 'Small Parts' Ultrasound Imaging

Philips receives U.S. FDA 510(k) clearance to market its solution for 'small parts' ultrasound imagingAMSTERDAM and TAIPEI, Taiwan, Oct. 13, 2017 /PRNewswire/ -- Royal Philips...

Abivax Presents Novel Data On The Efficacy Of Its Immune Enhancer ABX196 In Animal Model Of Liver Cancer At

PARIS--(BUSINESS WIRE)--Regulatory News: ABIVAX...

ImmunogenX Release: Dr. Joins The Scientific Advisory Board

Highly lauded celiac disease clinician joins the SAB of ImmunogenXImmunogenX is pleased to announce the addition of Markku Mki, MD, PhD to the Scientific Advisory Board of ImmunogenX. Dr. Mki is a Professor (Emeritus) at the University of Tampere and presently Research Director at the Tampere University Hospital, Tampere, Finland. He has an extensive track record...

ICU Medical Announces Time of Third Quarter 2017 Earnings Call

SAN CLEMENTE, Calif., Oct. 12, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its third quarter 2017 earnings release and...

Cytokinetics To Announce Third Quarter Results On October 26, 2017

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that it is scheduled to report third quarter results on October 26, 2017 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics senior management will host a conference...

Celsion To Host Research And Development (R&D) Day On Thursday, October 12, 2017

- Leading Experts to Discuss Clinical Programs in Primary Liver Cancer and Ovarian Cancer LAWRENCEVILLE, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology development company, today announced that it will host a Research and Development (R&...

CASI Pharma Announces $23.8 Million Registered Direct Offering Led By Existing Shareholders

ROCKVILLE, Md., Oct. 13, 2017 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (the "Company") (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial...


Quick Search
Advertisement
 

News Quicklinks